Server: Microsoft-IIS/3.0 Date: Thu, 18 Dec 1997 17:57:37 GMT Content-Type: text/html Accept-Ranges: bytes Last-Modified: Fri, 26 Sep 1997 16:39:44 GMT Content-Length: 1867
Memantine is being developed as a potential neuroprotective agent. Xerecept™ is being developed for the reduction of cerebral edema, initially in patients with brain tumors.
Profile | Pipeline | Financial | Stock Info | Neuroprotection | Press Releases | Glossary | Contacts